1. Zhu, Qingqing, Zhang, Chongguo, Qu, Tianyu, Guo, Renhua, Zhang, Erbao. . MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc-Mediated Cell-Cycle Progression and Proliferation in Lung Cancer. In Cancer research, 82, 4340-4358. doi:10.1158/0008-5472.CAN-22-1289. https://pubmed.ncbi.nlm.nih.gov/36214649/
2. Dworschak, Gabriel C, Reutter, Heiko M, Ludwig, Michael. 2021. Currarino syndrome: a comprehensive genetic review of a rare congenital disorder. In Orphanet journal of rare diseases, 16, 167. doi:10.1186/s13023-021-01799-0. https://pubmed.ncbi.nlm.nih.gov/33836786/
3. Bailey, Peter, Chang, David K, Nones, Katia, Biankin, Andrew V, Grimmond, Sean M. 2016. Genomic analyses identify molecular subtypes of pancreatic cancer. In Nature, 531, 47-52. doi:10.1038/nature16965. https://pubmed.ncbi.nlm.nih.gov/26909576/
4. Shuai, You, Ma, Zhonghua, Liu, Weitao, Xu, Tongpeng, Shu, Yongqian. 2020. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2. In Molecular cancer, 19, 6. doi:10.1186/s12943-019-1104-1. https://pubmed.ncbi.nlm.nih.gov/31924214/
5. Chi, Weiru, Xiu, Bingqiu, Xiong, Min, Chi, Yayun, Wu, Jiong. 2023. MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer. In International journal of molecular sciences, 25, . doi:10.3390/ijms25010221. https://pubmed.ncbi.nlm.nih.gov/38203393/